2oqi

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of, therapeutic agents for the treatment of type 2 diabetes. They exert their, beneficial effects by increasing the levels of active glucagon-like, peptide-1 and glucose-dependent insulinotropic peptide, which are two, important incretins for glucose homeostasis. Starting from a, high-throughput screening hit, we were able to identify a series of, piperidinone- and piperidine-constrained phenethylamines as novel DPP4, inhibitors. Optimized compounds are potent, selective, and have good, pharmacokinetic profiles.
+
Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of therapeutic agents for the treatment of type 2 diabetes. They exert their beneficial effects by increasing the levels of active glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, which are two important incretins for glucose homeostasis. Starting from a high-throughput screening hit, we were able to identify a series of piperidinone- and piperidine-constrained phenethylamines as novel DPP4 inhibitors. Optimized compounds are potent, selective, and have good pharmacokinetic profiles.
==About this Structure==
==About this Structure==
Line 10: Line 10:
==Reference==
==Reference==
-
Discovery and Structure-Activity Relationships of Piperidinone- and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors., Pei Z, Li X, Geldern TW, Longenecker K, Pireh D, Stewart KD, Backes BJ, Lai C, Lubben TH, Ballaron SJ, Beno DW, Kempf-Grote AJ, Sham HL, Trevillyan JM, J Med Chem. 2007 Mar 17;. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17367123 17367123]
+
Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors., Pei Z, Li X, von Geldern TW, Longenecker K, Pireh D, Stewart KD, Backes BJ, Lai C, Lubben TH, Ballaron SJ, Beno DW, Kempf-Grote AJ, Sham HL, Trevillyan JM, J Med Chem. 2007 Apr 19;50(8):1983-7. Epub 2007 Mar 17. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17367123 17367123]
[[Category: Dipeptidyl-peptidase IV]]
[[Category: Dipeptidyl-peptidase IV]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Backes, B.J.]]
+
[[Category: Backes, B J.]]
-
[[Category: Ballaron, S.J.]]
+
[[Category: Ballaron, S J.]]
-
[[Category: Beno, D.W.]]
+
[[Category: Beno, D W.]]
-
[[Category: Geldern, T.W.von.]]
+
[[Category: Geldern, T W.von.]]
-
[[Category: Kempf-Grote, A.J.]]
+
[[Category: Kempf-Grote, A J.]]
[[Category: Lai, C.]]
[[Category: Lai, C.]]
[[Category: Li, X.]]
[[Category: Li, X.]]
-
[[Category: Longenecker, K.L.]]
+
[[Category: Longenecker, K L.]]
-
[[Category: Lubben, T.H.]]
+
[[Category: Lubben, T H.]]
[[Category: Pei, Z.]]
[[Category: Pei, Z.]]
[[Category: Pireh, D.]]
[[Category: Pireh, D.]]
-
[[Category: Sham, H.L.]]
+
[[Category: Sham, H L.]]
-
[[Category: Stewart, K.D.]]
+
[[Category: Stewart, K D.]]
-
[[Category: Trevillyan, J.M.]]
+
[[Category: Trevillyan, J M.]]
[[Category: GGO]]
[[Category: GGO]]
[[Category: inhibitor]]
[[Category: inhibitor]]
[[Category: serine-peptidase]]
[[Category: serine-peptidase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:32:44 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:21:24 2008''

Revision as of 16:21, 21 February 2008


2oqi, resolution 2.800Å

Drag the structure with the mouse to rotate

Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine

Overview

Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of therapeutic agents for the treatment of type 2 diabetes. They exert their beneficial effects by increasing the levels of active glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, which are two important incretins for glucose homeostasis. Starting from a high-throughput screening hit, we were able to identify a series of piperidinone- and piperidine-constrained phenethylamines as novel DPP4 inhibitors. Optimized compounds are potent, selective, and have good pharmacokinetic profiles.

About this Structure

2OQI is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Dipeptidyl-peptidase IV, with EC number 3.4.14.5 Full crystallographic information is available from OCA.

Reference

Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors., Pei Z, Li X, von Geldern TW, Longenecker K, Pireh D, Stewart KD, Backes BJ, Lai C, Lubben TH, Ballaron SJ, Beno DW, Kempf-Grote AJ, Sham HL, Trevillyan JM, J Med Chem. 2007 Apr 19;50(8):1983-7. Epub 2007 Mar 17. PMID:17367123

Page seeded by OCA on Thu Feb 21 18:21:24 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools